Compare UG & IINN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UG | IINN |
|---|---|---|
| Founded | 1942 | 2018 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.8M | 35.3M |
| IPO Year | 1995 | N/A |
| Metric | UG | IINN |
|---|---|---|
| Price | $7.00 | $0.40 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.00 |
| AVG Volume (30 Days) | 5.7K | ★ 329.0K |
| Earning Date | 05-11-2026 | 03-26-2026 |
| Dividend Yield | ★ 7.10% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | ★ $10,545,468.00 | N/A |
| Revenue This Year | N/A | $16,841.18 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $35.85 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.58 | $0.34 |
| 52 Week High | $9.88 | $1.65 |
| Indicator | UG | IINN |
|---|---|---|
| Relative Strength Index (RSI) | 53.78 | 36.99 |
| Support Level | $6.31 | $0.39 |
| Resistance Level | $7.70 | $0.63 |
| Average True Range (ATR) | 0.30 | 0.04 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 43.59 | 9.21 |
United-Guardian Inc manufactures, markets and develops specialty cosmetic, personal care and sexual wellness ingredients, and a line of healthcare products including pharmaceuticals and medical lubricants. Its pharmaceutical products are distributed through national drug wholesalers to pharmacies, physicians, and hospitals. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. The company's majority of revenue is derived from the sales of Pharmaceuticals in the United States.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.